◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
圣湘生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 1.5B 1.0B 6.5B 4.5B 4.8B
Revenue Growth % 44.8% -84.4% 42.9% -5.2% --
Total Revenue 1.5B 1.0B 6.5B 4.5B 4.8B
Cost Of Revenue 322.0M 287.0M 2.7B 1.3B 970.0M
+Gross Profit 1.1B 720.0M 3.8B 3.2B 3.8B
Gross Margin % 77.9% 71.5% 58.8% 71.7% 79.6%
Total Operating Cost 1.2B 975.0M 4.2B 2.0B 1.7B
Selling Expenses 500.0M 358.0M 732.0M 392.0M 520.0M
Admin Expenses 252.0M 189.0M 211.0M 99.1M 85.1M
Rd Expenses 278.0M 196.0M 332.0M 188.0M 82.8M
Finance Expenses -85.3M -53.5M -50.4M 11.5M 28.0M
+Operating Income 278.0M 427.0M 2.3B 2.6B 3.1B
Operating Margin % 19.1% 42.4% 36.3% 58.1% 64.8%
Non Operating Income 1.8M 1.5M 1.7M 12.5M 6.5M
Non Operating Expenses 18.9M 18.5M 25.6M 18.1M 22.4M
Investment Income -28.8M 254.0M -19.9M -5.1M 16.3M
Fair Value Change Income 8.4M 61.8M 99.1M 86.1M 6.2M
Asset Disposal Income -2.4M -247,900 -314,000 2.8M 3.5M
Asset Impairment Loss -43.8M -7.5M 269.0M 12,200 --
Other Income 91.8M 79.8M 41.1M 25.2M 18.5M
Income Before Tax 261.0M 410.0M 2.3B 2.6B 3.1B
Income Tax 34.3M 62.3M 379.0M 374.0M 454.0M
+Net Income 226.0M 348.0M 1.9B 2.2B 2.6B
Net Margin % 15.5% 34.6% 30.0% 49.7% 54.9%
Net Income Attributable 276.0M 364.0M 1.9B 2.2B 2.6B
Minority Interest -49.3M -15.6M -93,600 -172,600 --
Eps Basic 0.47 0.62 3.31 3.81 7.01
Eps Diluted 0.47 0.62 3.31 3.81 7.01
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 4.6B 4.2B 3.2B 2.6B 2.6B
Trading Financial Assets 140.0M 548.0M 2.5B 2.0B 1.6B
Accounts Receivable 529.0M 690.0M 1.3B 795.0M 521.0M
Notes Receivable 157,100 2.7M 21.8M 12.9M 25.7M
Notes And Accounts Receivable 530.0M 692.0M 1.3B 808.0M 546.0M
Prepayments 37.2M 53.7M 92.2M 72.1M 42.8M
Inventory 393.0M 377.0M 355.0M 370.0M 277.0M
Total Current Assets 5.8B 6.0B 7.5B 6.0B 5.1B
Long Term Equity Investment 375.0M 209.0M 295.0M 256.0M --
Fixed Assets -- 1.0B 489.0M 355.0M 215.0M
Fixed Assets Total 1.1B 1.0B 489.0M 355.0M 215.0M
Construction In Progress -- 4.6M 268.0M 110.0M 1.8M
Construction In Progress Total 3.6M 4.6M 268.0M 110.0M 1.8M
Intangible Assets 335.0M 283.0M 79.1M 45.6M 31.2M
Long Term Deferred Expenses 52.6M 52.4M 41.4M 16.3M 4.2M
Total Non Current Assets 2.8B 2.5B 1.6B 1.1B 372.0M
Total Assets 8.6B 8.5B 9.2B 7.1B 5.5B
Short Term Borrowings 9.0M 9.0M -- -- 55.0M
Accounts Payable 375.0M 469.0M 791.0M 259.0M 272.0M
Advance Receipts -- -- -- -- --
Contract Liabilities 64.6M 32.8M 53.1M 78.6M 62.5M
Total Current Liabilities 755.0M 919.0M 1.6B 664.0M 689.0M
Long Term Borrowings 397.0M -- -- -- --
Total Non Current Liabilities 503.0M 110.0M 89.3M 45.1M 20.3M
Total Liabilities 1.3B 1.0B 1.7B 709.0M 709.0M
Paid In Capital 582.0M 588.0M 588.0M 400.0M 400.0M
Capital Reserve 1.7B 1.9B 1.9B 2.1B 2.1B
Surplus Reserve 294.0M 294.0M 294.0M 262.0M 262.0M
Retained Earnings 4.9B 4.9B 5.1B 3.8B 2.0B
Minority Equity 103.0M 224.0M 12.2M 12.4M --
Equity Attributable 7.2B 7.2B 7.5B 6.4B 4.7B
Total Equity 7.3B 7.4B 7.5B 6.4B 4.7B
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...